Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
Work
Year: 2022
Type: article
Abstract: To evaluate long-term efficacy (percent seizure frequency reduction and responder rates), safety, and tolerability of adjunctive cenobamate (CNB) in an open-label extension (OLE) of the randomized, do... more
Source: Neurology
Institutions Johns Hopkins University, Bethel University, SK Life Science (United States), Mid Atlantic Epilepsy and Sleep Center, University of Freiburg +4 more
Cites: 22
Cited by: 59
Related to: 10
FWCI: 12.29
Citation percentile (by year/subfield): 82.26
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid